Bertold Emmerich
Impact in
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 44
- Chronic Lymphocytic Leukemia Research 41
- Co-authors
- Michael Hallek (35 shared papers)Ralf Schmidmaier (12 shared papers)Philipp Baumann (7 shared papers)Gerold Meinhardt (8 shared papers)Wolfgang Hiddemann (4 shared papers)Raymonde Busch (9 shared papers)Alex Smith (1 shared paper)Gunnar Juliusson (1 shared paper)
- Journals
- Blood (14 papers)British Journal of Haematology (10 papers)Annals of Hematology (8 papers)Journal of Molecular Medicine (5 papers)Leukemia (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Bertold Emmerich
110 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 109
- Genetics 1.7k
- Hematology 871
- Pathology and Forensic Medicine 1.2k
- Immunology 1.1k
- Oncology 679
Countries citing papers authored by Bertold Emmerich
This map shows the geographic impact of Bertold Emmerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertold Emmerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertold Emmerich more than expected).
Fields of papers citing papers by Bertold Emmerich
This network shows the impact of papers produced by Bertold Emmerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertold Emmerich. The network helps show where Bertold Emmerich may publish in the future.
Co-authors
The 25 scholars most cited alongside Bertold Emmerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 369 | |
| 2 | 2009 | 248 | |
| 3 | 2004 | 205 | |
| 4 | 1999 | 183 | |
| 5 | 1999 | 131 | |
| 6 | 2002 | 130 | |
| 7 | 1997 | 107 | |
| 8 | 2005 | 106 | |
| 9 | Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group. | 2005 | 106 |
| 10 | 2004 | 102 | |
| 11 | 2001 | 101 | |
| 12 | 1992 | 95 | |
| 13 | 1995 | 87 | |
| 14 | 2002 | 80 | |
| 15 | Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines. | 1997 | 65 |
| 16 | 2002 | 62 | |
| 17 | 2007 | 60 | |
| 18 | 2007 | 57 | |
| 19 | 2006 | 55 | |
| 20 | 2007 | 54 |
About Bertold Emmerich
Bertold Emmerich is a scholar working on Genetics, Molecular Biology, Pathology and Forensic Medicine, Hematology and Oncology, having authored 117 papers that have together received 3.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (41 papers), Lymphoma Diagnosis and Treatment (28 papers), Acute Lymphoblastic Leukemia research (13 papers), Immunodeficiency and Autoimmune Disorders (10 papers), Multiple Myeloma Research and Treatments (10 papers), Chronic Myeloid Leukemia Treatments (9 papers), Acute Myeloid Leukemia Research (8 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Genetics (1.7k citations), Hematology (871 citations), Pathology and Forensic Medicine (1.2k citations), Immunology (1.1k citations) and Oncology (679 citations). Bertold Emmerich has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Michael Hallek, Ralf Schmidmaier, Philipp Baumann, Gerold Meinhardt, Wolfgang Hiddemann, Raymonde Busch, Alex Smith, Gunnar Juliusson, P.J. Wyld and H. Löffler. Their work appears in journals such as Blood, British Journal of Haematology, Annals of Hematology, Journal of Molecular Medicine and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.